Comprehensive, up-front full-panel NGS across lung cancer stages is preferred to conserve tissue and avoid sequential testing ...

Pegvisomant, developed by professor John Kopchick in 1987, shows potential to make treatment-resistant lung cancer cells more ...

Andrew Joseph covers health, medicine, and the biopharma industry in Europe. You can reach Andrew on Signal at drewqjoseph.71. In the United States and elsewhere, there’s been a major shift in ...

The disease is the rare cancer met with accusations, not sympathy. By Simar Bajaj Simar Bajaj spoke to over a dozen patients with lung cancer for this story. When Jim Pantelas was diagnosed with lung ...

Barry Manilow is recovering after catching a "cancerous spot" on his lung early. The 82-year-old singer revealed on Instagram that a lengthy bout with bronchitis led to the discovery of the cancer ...

Scientists used CRISPR to disable the NRF2 gene, restoring chemotherapy sensitivity in lung cancer cells and slowing tumor growth. The technique worked even when only a fraction of tumor cells were ...

aDepartment of Medical Oncology, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Sun Yat-Sen University Cancer Center, Guangzhou, China bState Key ...

Describes the nature of a clinical study. Types include: Observational study — observes people and measures outcomes without affecting results. Interventional study (clinical trial) — studies new ...

Chandler H. Park, MD, discusses NCCN treatment regimens for patients with metastatic bladder cancer. Chandler H. Park, MD, a medical oncologist at Norton Cancer Institute and advisory dean/professor ...

The introduction of enfortumab vedotin combined with pembrolizumab (EV-P) as a first-line treatment for advanced urothelial carcinoma (UC) has transformed the therapeutic landscape and holds great ...

Camrelizumab with carboplatin and nab-paclitaxel shows potential as a first-line treatment for ES-SCLC, with promising survival rates. The study identified biomarkers, including MUC17 alterations and ...